Critical appraisal of proton therapy for patients with Central Nervous System (CNS) Malignancies
J Kahan, C Martinez, C Tsien - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement As more hospital-based proton treatment centres become operational,
the indications for proton beam therapy (PBT) are being evaluated. Recent advances in PBT …
the indications for proton beam therapy (PBT) are being evaluated. Recent advances in PBT …
[HTML][HTML] Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
JPM Jaspers, W Taal, Y van Norden, JD Zindler… - Radiotherapy and …, 2023 - Elsevier
Objective The interpretation of new enhancing lesions after radiotherapy for diffuse glioma
remains a clinical challenge. We sought to characterize and classify new contrast enhancing …
remains a clinical challenge. We sought to characterize and classify new contrast enhancing …
Three-dimensional arterial spin labeling-guided sub-volume segmentation of radiotherapy in adult non-enhancing low-grade gliomas
Z Zhu, G Gong, L Wang, Y Su, J Lu, Y Yin - Frontiers in Oncology, 2022 - frontiersin.org
Objective The present study aimed to evaluate the feasibility of sub-volume segmentation for
radiotherapy planning of adult non-enhancing low-grade gliomas (NE-LGGs) guided by …
radiotherapy planning of adult non-enhancing low-grade gliomas (NE-LGGs) guided by …
Orthotopic glioblastoma models for evaluation of the clinical target volume concept
R Bütof, P Hönscheid, R Aktar, C Sperling, F Tillner… - Cancers, 2022 - mdpi.com
Simple Summary The accurate and precise definition of the target volume is of enormous
importance for the treatment success of radiotherapy. In glioblastoma, the microscopic tumor …
importance for the treatment success of radiotherapy. In glioblastoma, the microscopic tumor …
[HTML][HTML] ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma
Purpose This guideline will discuss radiotherapeutic management of IDH mutant grade 2
and grade 3 diffuse glioma, using the latest 2021 WHO (5th) classification of brain tumours …
and grade 3 diffuse glioma, using the latest 2021 WHO (5th) classification of brain tumours …
Three-dimensional arterial spin labeling-guided dose painting radiotherapy for non-enhancing low-grade gliomas
Z Zhu, G Gong, L Wang, Y Su, J Lu, Y Yin - Japanese Journal of Radiology, 2023 - Springer
Purpose To investigate the feasibility and dosimetric characteristics of dose painting for non-
enhancing low-grade gliomas (NE-LGGs) guided by three-dimensional arterial spin labeling …
enhancing low-grade gliomas (NE-LGGs) guided by three-dimensional arterial spin labeling …
A Study of Dose Painting Guided by Three-Dimensional Arterial Spin Labeling for Non-Enhancing Low-Grade Gliomas During Radiotherapy
Z Zhu, G Gong, L Wang, Y Su, J Lu, Y Yin - 2022 - researchsquare.com
Background: The purpose of this study was to investigate the feasibility and dosimetric
characteristics of dose painting for non-enhancing low-grade gliomas (NE-LGGs) guided by …
characteristics of dose painting for non-enhancing low-grade gliomas (NE-LGGs) guided by …
A Study of Dose Painting Radiotherapy Guided by Three-Dimensional Arterial Spin labeling Perfusion Magnetic Resonance Imaging for Non-Enhancing Low-Grade …
Z Zhu, G Gong, L Wang, Y Su, X Qin, M Chen, J Lu… - 2021 - researchsquare.com
Background: The purpose of this study was to investigate the feasibility and dosimetric
characteristics of dose painting for non-enhancing low-grade gliomas (NE-LGGs) guided by …
characteristics of dose painting for non-enhancing low-grade gliomas (NE-LGGs) guided by …
[引用][C] Überlebensdaten, Progressionsmuster und Toxizität nach Strahlentherapie von niedrig gradigen Gliomen
HJ Presse - 2023 - Dissertation, Universität Freiburg …